4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Clinical trial NCT06864988 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06864988
- Sponsor
- 4D Molecular Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-03
- Primary completion
- 2027-06-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.